Cue Health Inc.
NASDAQ:HLTH
0.0434 (USD) • At close June 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 10.054 | 18.798 | 14.757 | 7.591 | 24.494 | 146.777 | 66.66 | 84.351 | 177.454 | 192.506 | 223.679 | 137.423 | 64.499 | 13.263 | 4.73 |
| Cost of Revenue
| 16.317 | 35.742 | 22.18 | 29.346 | 39.823 | 90.783 | 50.595 | 101.898 | 86.697 | 102.796 | 88.569 | 55.142 | 30.035 | 12.31 | 2.641 |
| Gross Profit
| -6.263 | -16.944 | -7.423 | -21.755 | -15.329 | 55.994 | 16.065 | -17.547 | 90.757 | 89.71 | 135.11 | 82.281 | 34.464 | 0.953 | 2.089 |
| Gross Profit Ratio
| -0.623 | -0.901 | -0.503 | -2.866 | -0.626 | 0.381 | 0.241 | -0.208 | 0.511 | 0.466 | 0.604 | 0.599 | 0.534 | 0.072 | 0.442 |
| Reseach & Development Expenses
| 29.276 | 32.248 | 37.103 | 36.536 | 44.733 | 56.149 | 42.516 | 44 | 28.787 | 21.679 | 9.079 | 4.662 | 7.409 | 1.92 | 6.878 |
| General & Administrative Expenses
| 0 | 9.866 | 15.848 | 14.703 | 16.938 | 19.157 | 25.625 | 25.411 | 26.91 | 23.452 | 33.084 | 11.382 | 11.87 | 16.478 | 3.694 |
| Selling & Marketing Expenses
| 0 | 6.226 | 7.051 | 8.059 | 11.248 | 19.312 | 18.129 | 16.971 | 34.168 | 21.198 | 5.572 | 1.529 | 0.43 | 0.65 | 0.019 |
| SG&A
| 8.499 | 16.092 | 22.899 | 22.762 | 28.186 | 38.469 | 43.754 | 42.382 | 61.078 | 44.65 | 38.656 | 12.911 | 12.3 | 17.128 | 3.713 |
| Other Expenses
| 0 | -5.363 | 1.833 | 1.82 | -0.271 | 2.035 | -2.929 | -3.349 | -1.956 | 0.291 | -36.386 | -23.23 | 0.037 | -0.052 | 0.04 |
| Operating Expenses
| 37.775 | 48.34 | 36.343 | 56.993 | 72.648 | 94.618 | 83.341 | 83.033 | 87.909 | 66.329 | 47.735 | 17.573 | 19.709 | 19.048 | 10.591 |
| Operating Income
| -44.038 | -65.284 | -64.705 | -85.393 | -95.85 | -38.624 | -67.276 | -102.463 | 2.848 | 23.381 | 87.375 | 64.708 | 14.755 | -18.095 | -8.502 |
| Operating Income Ratio
| -4.38 | -3.473 | -4.385 | -11.249 | -3.913 | -0.263 | -1.009 | -1.215 | 0.016 | 0.121 | 0.391 | 0.471 | 0.229 | -1.364 | -1.797 |
| Total Other Income Expenses Net
| -5.478 | -83.088 | 22.468 | 1.529 | 1.652 | 1.803 | -0.074 | 0.027 | -0.045 | 0.234 | -37.929 | -32.849 | -0.498 | -1.441 | -0.036 |
| Income Before Tax
| -49.516 | -148.372 | -42.237 | -83.864 | -94.198 | -36.821 | -67.35 | -102.436 | 2.803 | 23.615 | 49.446 | 31.859 | 14.257 | -19.536 | -8.538 |
| Income Before Tax Ratio
| -4.925 | -7.893 | -2.862 | -11.048 | -3.846 | -0.251 | -1.01 | -1.214 | 0.016 | 0.123 | 0.221 | 0.232 | 0.221 | -1.473 | -1.805 |
| Income Tax Expense
| 0 | 0.06 | 4.733 | 2.111 | -1.432 | -5.315 | -1.047 | -3.386 | 0.045 | -10.615 | 30.098 | 12.05 | 1.226 | 0.658 | 0.076 |
| Net Income
| -49.516 | -148.432 | -46.97 | -83.864 | -92.766 | -31.506 | -66.303 | -99.05 | 2.803 | 34.23 | 19.348 | 19.809 | 13.031 | -19.536 | -8.538 |
| Net Income Ratio
| -4.925 | -7.896 | -3.183 | -11.048 | -3.787 | -0.215 | -0.995 | -1.174 | 0.016 | 0.178 | 0.086 | 0.144 | 0.202 | -1.473 | -1.805 |
| EPS
| -0.31 | -0.96 | -0.31 | -0.55 | -0.61 | -0.21 | -0.45 | -0.67 | 0.019 | 0.23 | 0.14 | 0.019 | 0.013 | -0.15 | -0.067 |
| EPS Diluted
| -0.31 | -0.96 | -0.31 | -0.55 | -0.61 | -0.21 | -0.45 | -0.67 | 0.018 | 0.22 | 0.13 | 0.019 | 0.013 | -0.14 | -0.063 |
| EBITDA
| -44.038 | -50.065 | -41.933 | -64.572 | -86.105 | -36.589 | -55.463 | -89.558 | 13.46 | 23.672 | 62.568 | 51.094 | 19.676 | -16.232 | -6.944 |
| EBITDA Ratio
| -4.38 | -2.663 | -2.842 | -8.506 | -3.515 | -0.249 | -0.832 | -1.062 | 0.076 | 0.123 | 0.28 | 0.372 | 0.305 | -1.224 | -1.468 |